Ana Kutschat selected for training program by EHA and EMBL-EBI (Vienna, 21.12.2022) The European Hematology Association (EHA) and EMBL’s European Bioinformatics Institute (EMBL-EBI) selected Ana Kutschat, postdoc in Davide Seruggia´s research group at St. Anna Children´s Cancer Research Institute (St. Anna CCRI) as one of only 20 favored young scientists to participate in the 2023 […]
St. Anna Children’s Cancer Research Institute and its collaboration partner CeMM receive funding for a project aimed at providing tailored treatments for a type of childhood leukemia not adequately addressed by current therapy.
Prof. Christina Peters, MD, from St. Anna Children’s Hospital and St. Anna CCRI presents new data showing a dire need for immunotherapy strategies tackling high-risk childhood leukemia at the Annual Meeting of the American Society of Hematology (ASH). Other updates from the same study (FORUM) confirm the superiority of total body irradiation prior to stem cell transplantation and the use of transplants from matched unrelated donors in children under the age of four with high-risk acute lymphoblastic leukemia (ALL).
Delighted to present at ASH: Three updates on the FORUM trial Read More »
How adult drugs from the group of MAP kinase inhibitors can also be used in children with cancer in a standardized manner worldwide has now been outlined in a statement in the renowned European Journal of Cancer. The authors of this review are stakeholders from all relevant fields, including Caroline Hutter, MD, PhD, scientist at St. Anna Children’s Cancer Research Institute, clinician at St. Anna Children’s Hospital and expert in the rare pediatric cancer Langerhans cell histiocytosis (LCH). Her goal is to test the most effective and tolerable MAP kinase inhibitor in a clinical trial, thus enabling rapid market approval and availability for children.
How to make latest cancer therapies also available for children Read More »
On hot track! Davide Seruggia and Ana Kutschat focus on new epigenetic factors associated with risk of developing childhood leukemia.
St. Anna CCRI attends “Better Medicines for Children Conference 2022” (Vienna, 20.10.2022) We are happy to attend the “EFGCP Better Medicines for Children Conference 2022” with Ruth Ladenstein (Principal Investigator at St. Anna CCRI) presenting the EU funded “European Rare Disease Research Coordination and Support Action – ERICA” in the panel discussion “Rare diseases –
St. Anna CCRI attends “Better Medicines for Children Conference 2022” Read More »
This year, all three prizes, as well as the “best abstract of the conference” go to St. Anna Children’s Cancer Research Institute (St. Anna CCRI) and St. Anna Children’s Hospital!
…and the ÖGMBT Best Talk Award goes to: Eva König!
…and the ÖGMBT Best Talk Award goes to: Eva König! Read More »
Socializing, getting further education and screening job offers: This year’s Life Science Career Fair of the ÖGMBT offered a wide range of opportunities for students and graduates.
A great success! Dr. Eva König, principal investigator at St. Anna CCRI, is honored with the Heribert-Konzett-Prize of the Austrian Pharmacological Society (APHAR) for her scientific work on the interaction between immune and cancer cells. The prize is awarded to recognize the achievements of young scientists already conducting independent research in the field of experimental and clinical pharmacology and to encourage their further development.
Eva König wins Heribert-Konzett-Prize! Read More »
Evolution 2.0: What makes cancer more malignant (Vienna, 23.09.2022) Congratulations! A paper has just been published in the top journal Nature Genetics, with the participation of Dr. Sabine Taschner-Mandl and Dr. Marie Bernkopf from St. Anna CCRI. The authors of this outstanding paper show that random inheritance patterns of cancer genes outside the chromosome, i.e. the scaffold
Evolution 2.0: What makes cancer more malignant Read More »
St. Anna CCRI epigenetics researcher Peter Peneder wins ÖGMBT-award! (Vienna, 20.09.2022) Well done! First place at the Life Science Research Awards Austria 2022 in the category Excellence and Societal Impact – Peter Peneder from Dr. Eleni Tomazou´s tumor epigenetics research group at St. Anna CCRI convinced the jury of the Austrian Society for Molecular Biosciences and
St. Anna CCRI epigenetics researcher Peter Peneder wins ÖGMBT-award! Read More »
Nerve healing: neighboring cells become police force – and could make tumors benign (Vienna, 15.09.2022) Scientists from St. Anna Children´s Cancer Research Institute (St. Anna CCRI) discovered a completely new function of the cells that surround nerve fibers: so-called Schwann cells not only attract immune cells to initiate nerve healing, but also behave like a “police force”
Nerve healing: neighboring cells become police force – and could make tumors benign Read More »
Scientists off the record: In our summer interview series, St. Anna Children’s Cancer Researcher Florian Halbritter shares not only his summer reading shortlist, but also his best advice to bring forward great ideas.
Florian Halbritter: “Be open and curious, listen, learn, adapt, and improve.” Read More »
Pediatric cancer researchers publish collection of leukemia reviews in top journal “Frontiers in Pediatrics”.
According to the authors, new therapies could spare some children a stem cell transplantation.
Childhood Leukemia treatment 2022: where we are now and what it takes Read More »
September is Childhood Cancer Awareness Month – a month dedicated to remind us of the dire need to find more and better cures for this devastating disease.
Gold and Brave against Childhood Cancer Read More »
